<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It has previously been shown that <z:chebi fb="0" ids="52289">Wortmannin</z:chebi>, a phosphatidylinositol 3-kinase inhibitor, inhibits <z:chebi fb="105" ids="17234">glucose</z:chebi> transport activated by insulin but not by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, suggesting the importance of an activating mechanism that bypasses the insulin signal </plain></SENT>
<SENT sid="1" pm="."><plain>To evaluate the relevance of this insulin-independent pathway in insulin-resistant subjects, the ability of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> to stimulate <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake was investigated in 9 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and in 9 healthy control subjects (fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> level 9.4 +/- 0.8 vs. 5.1 +/- 0.1 mmol/l, P &lt; 0.001, in type 2 diabetic patients and control subjects, respectively; fasting insulin level insulin 8.1 +/- 2.6 vs. 4.5 +/-0.7 mU/l, P &lt; 0.05, respectively) matched for sex, age, and BMI </plain></SENT>
<SENT sid="2" pm="."><plain>Arterial plasma and interstitial concentrations of <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="4" ids="24996">lactate</z:chebi> (measured by subcutaneous and muscle microdialysis) were recorded in the forearm before, during, and after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> induced locally for 20 min </plain></SENT>
<SENT sid="3" pm="."><plain>During <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, the muscle interstitial <z:chebi fb="105" ids="17234">glucose</z:chebi> concentration decreased significantly from 7.7 +/- 0.6 to 5.4 +/- 0.4 mmol/l (P &lt; 0.01) and from 4.4 +/- 0.3 to 3.6 +/- 0.3 mmol/l (P &lt; 0.05) in type 2 diabetic patients and control subjects, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>The arterial-interstitial (A-I) <z:chebi fb="105" ids="17234">glucose</z:chebi> concentration difference was 1.7 +/- 0.6 and 0.7 +/- 0.3 mmol/ at basal, and it increased significantly to 3.5 +/- 0.7 (P &lt; 0.01) and 1.4 +/-0.3 mmol/l (P &lt; 0.05) during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in each group, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Interstitial <z:chebi fb="4" ids="24996">lactate</z:chebi> increased significantly during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> from 0.8 +/- 0.1 to 1.1 +/- 0.1 mmol/l (P &lt; 0.05) and from 0.5 +/- 0.1 to 0.9 +/- 0.2 mmol/l (P &lt; 0.05), respectively </plain></SENT>
<SENT sid="6" pm="."><plain>The A-I <z:chebi fb="105" ids="17234">glucose</z:chebi> concentration difference was abolished immediately postischemia and regained after approximately 15 min, whereas high interstitial <z:chebi fb="4" ids="24996">lactate</z:chebi> levels remained elevated throughout the study </plain></SENT>
<SENT sid="7" pm="."><plain>Subcutaneous interstitial <z:chebi fb="105" ids="17234">glucose</z:chebi> concentrations remained unchanged during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and postischemia in both groups, whereas the interstitial <z:chebi fb="4" ids="24996">lactate</z:chebi> concentration in adipose tissue increased during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> from 1.4 +/- 0.2 to 2.0 +/- 0.2 mmol/l (P &lt; 0.05) and from 1.1 +/- 0.1 to 1.8 +/- 0.3 mmol/l (P &lt; 0.05) in type 2 diabetic patients and control subjects, respectively </plain></SENT>
<SENT sid="8" pm="."><plain>Plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="4" ids="24996">lactate</z:chebi> levels were unchanged in both groups during the study period </plain></SENT>
<SENT sid="9" pm="."><plain>The results show that in muscle, but not in adipose tissue, <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake is efficiently activated by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in insulin-resistant type 2 diabetic subjects, suggesting the activation of a putative alternative pathway to the insulin signal in muscle cells </plain></SENT>
</text></document>